Literature DB >> 3047582

The molecular genetics of Philadelphia chromosome-positive leukemias.

R Kurzrock1, J U Gutterman, M Talpaz.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3047582     DOI： 10.1056/NEJM198810133191506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  114 in total

Review 1.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors:  B J Druker; N B Lydon
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Acute lymphoblastic leukemia with t(1;9;22)(q32;q34;q11).

Authors:  Shin Fujisawa; Heiwa Kanamori; Maki Takabayashi; Masatsugu Tanaka; Satoshi Yamaji; Naoto Tomita; Katsumichi Fujimaki; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

3.  Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era.

Authors:  Haiyan He; Yang Shen; Yongmei Zhu; Saijuan Chen
Journal:  Front Med       Date:  2012-06-03       Impact factor: 4.592

4.  BCR/ABL inhibition by an escort/phosphatase fusion protein.

Authors:  Y M Lim; S Wong; G Lau; O N Witte; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells.

Authors:  Nataliia V Guz; Sapan J Patel; Maxim E Dokukin; Bayard Clarkson; Igor Sokolov
Journal:  Nanomedicine       Date:  2016-07-16       Impact factor: 5.307

Review 6.  RAS inhibitors in hematologic cancers: biologic considerations and clinical applications.

Authors:  D M Beaupre; R Kurzrock
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.

Authors:  Zhanxiang Wang; Louis M Pelus
Journal:  Cancer Ther       Date:  2008

8.  Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.

Authors:  K Senechal; C Heaney; B Druker; C L Sawyers
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells.

Authors:  K R LaMontagne; G Hannon; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.